SEC Filing Summary: Form 13F Information Table
Business Context and Reporting Period
Company: GENWORTH FINANCIAL INC
Filing Type: Form 13F Information Table
Reporting Period: December 31, 2023
Context: This filing discloses the equity securities held by Genworth Financial Inc. as of the end of the reporting period. It is a regulatory disclosure of investment holdings, not a financial performance report.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics for Genworth Financial Inc. Form 13F filings strictly list investment holdings and do not contain the issuer's operational financial statements.
| Issuer Name | Title of Class | Shares Held | Value (USD) | Voting Authority |
|---|---|---|---|---|
| POWERSHARES S&P 500 LOW VOLATILITY | COM | 455,287 | 28,528,283 | Sole |
| ISHARES CORE S&P 500 INDEX ETF | COM | 601,470 | 287,280,116 | Sole |
| MIRUM PHARMACEUTICALS INC | COM | 13,051 | 385,266 | Sole |
| UDEMY INC | COM | 130 | 1,915 | Sole |
Material Changes
The filing text does not provide data for the prior comparable period; therefore, material changes in holdings cannot be determined from this document alone.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. This form is a static snapshot of holdings.
Investor Verification Checklist
- Verify the total value of the disclosed portfolio against the company's latest 10-K or 10-Q for context on asset allocation.
- Confirm the specific CUSIP numbers for the listed ETFs and equities to ensure accurate identification of holdings.
- Note that voting authority for all listed positions is reported as "Sole."
- Understand that this filing does not reflect the company's own financial health, only its investment portfolio.